StemCell Institute Inc. engages in the stem cell banking business in Japan. The company is involved in Cell management and transportation services; extraction, purification, processing, storage, testing, and sale of components derived from biological tissues; research, and development, and dissemination of cell-based therapies. Its also offers the manufacturing, wholesale distribution, and sale of pharmaceuticals and medical devices. In addition, the company operates and manages medical facilities, conducts real estate leasing and property management activities, and provides information processing, information, and advertising services, as well as business control and management functions to support its overall operations and affiliated business activities. StemCell Institute Inc. was incorporated in 1999 and is headquartered in Tokyo, Japan. StemCell Institute Inc. is a subsidiary of Trim Medical Holdings Inc.
Frequently asked questions
What sector does StemCell Institute Inc. (7096) operate in?
StemCell Institute Inc. belongs to the Healthcare sector and operates in the Biotechnology industry.
What is StemCell Institute Inc. (7096) current stock price?
As of the latest data, StemCell Institute Inc. stock price is ¥643, with a previous close of ¥640. StemCell Institute Inc. gained ¥3 in the last trading session, representing a 0.47% increase.
What is StemCell Institute Inc. (7096) current market capitalization?
StemCell Institute Inc. market cap is approximately 6.48 billion.
What is StemCell Institute Inc. (7096) Earnings Per Share (EPS)?
The trailing EPS is ¥15, and the forward EPS is ¥20.
What is StemCell Institute Inc. (7096) Price-to-Earnings (P/E) ratio?
StemCell Institute Inc. current P/E ratio is 43.68, with a forward P/E of 32.31.
What is StemCell Institute Inc. (7096) EBITDA?
StemCell Institute Inc. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 41.38 million.
Does StemCell Institute Inc. (7096) pay dividends?
No. StemCell Institute Inc. does not pay a dividend.
What is StemCell Institute Inc. (7096) beta (volatility) score?
StemCell Institute Inc. has a beta of 0.650, indicating lower volatility than the overall market.